INSIGHTS ON DRUG DEVELOPMENT

• Accelerating Discovery Success With Structure-Guided Drug Design

  Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.

• Bioprocess Training And Education

  Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

• Direct API Capsule Filling: A Faster Path To Market

  Direct API capsule filling eliminates complex formulation steps, leveraging volumetric drum dosing and 100% net weight verification to accelerate drug development timeline efficiency.

• 5 Trends Impacting CMOs In 2025

  In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.

• Matrigel Dome Assay And Drug Screening Of Colorectal Cancer Organoids

  3/31/2025

  Using CRC organoids and bioprinting, explore the automation of dome assays to evaluate drug responses and delve into the insights from image-based end-point assays on the efficacy of anti-cancer treatments.

• If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?

  3/17/2026

  Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?

• The Rise Of Complex OSD Generics: Understanding Development Challenges

  12/11/2024

  Understanding the potential pitfalls and partnering with the right experts can make all the difference in overcoming the complexities of complex generic OSD development.

• Neoantigen-Based Personalized Cancer Vaccine

  7/1/2026

  Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.

• Choosing The Best Amorphous Dispersion Path Before It Costs You

  6/22/2026

  Parallel screening across multiple solid dispersion platforms early optimizes drug solubility and stability, building a strong technical foundation that prevents costly development delays.